Provided by Tiger Fintech (Singapore) Pte. Ltd.

ProPhase Labs

0.5150
+0.134935.49%
Post-market: 0.4824-0.0326-6.33%18:42 EDT
Volume:17.10M
Turnover:7.89M
Market Cap:21.39M
PE:-0.38
High:0.5200
Open:0.3900
Low:0.3400
Close:0.3801
52wk High:2.97
52wk Low:0.2179
Shares:41.54M
Float Shares:38.22M
Volume Ratio:9.70
T/O Rate:44.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3672
EPS(LYR):-2.6078
ROE:-171.81%
ROA:-28.85%
PB:1.87
PE(LYR):-0.20

Loading ...

Company Profile

Company Name:
ProPhase Labs
Exchange:
NASDAQ
Establishment Date:
1989
Employees:
96
Office Location:
711 Stewart Avenue,Suite 200,Garden City,New York,United States
Zip Code:
11530
Fax:
- -
Introduction:
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Directors

Name
Position
Ted Karkus
Chairman of the Board and Chief Executive Officer
Carolina Abenante
Director
Louis Gleckel
Director
Warren Hirsch
Director

Shareholders

Name
Position
Ted Karkus
Chairman of the Board and Chief Executive Officer